PRGO logo

Perrigo Stock Price

Symbol: NYSE:PRGOMarket Cap: US$3.7bCategory: Pharmaceuticals & Biotech

PRGO Share Price Performance

US$26.64
-2.06 (-7.18%)
27.0% undervalued intrinsic discount
US$36.50
Fair Value
US$26.64
-2.06 (-7.18%)
27.0% undervalued intrinsic discount
US$36.50
Fair Value
Price US$26.64
AnalystConsensusTarget US$36.50

PRGO Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$36.50 27.0% undervalued intrinsic discount

Americas Awards And Supply Chain Savings Will Fuel Future Performance

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

PRGO Community Fair Values

Recent PRGO News & Updates

No updates

Perrigo Company plc Key Details

US$4.3b

Revenue

US$2.8b

Cost of Revenue

US$1.6b

Gross Profit

US$1.7b

Other Expenses

-US$164.7m

Earnings

Last Reported Earnings
Mar 29, 2025
Next Reporting Earnings
Aug 06, 2025
Earnings per share (EPS)
-1.20
Gross Margin
36.38%
Net Profit Margin
-3.80%
Debt/Equity Ratio
83.5%

Perrigo Company plc Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About PRGO

Founded
1887
Employees
8379
CEO
Patrick Lockwood-Taylor
WebsiteView website
www.perrigo.com

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Irish Market Performance

  • 7 Days: -4.6%
  • 3 Months: 3.6%
  • 1 Year: 19.5%
  • Year to Date: 14.2%
Over the past 7 days, the market has dropped 4.6% with the Financials sector contributing the most to the decline. As for the longer term, the market has actually risen by 19% in the last year. Earnings are forecast to grow by 6.9% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading